UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of Earliest Event Reported): ~~January~~October 201, ~~2023~~2025

~~DSWISS~~DSwiss, ~~INC~~Inc.

(Exact name of registrant issuer as specified in its charter)

Nevada	333-208083	47-4215595
(State or other jurisdiction of incorporation)	(Commission File Number)	(IRS Employer Identification No.)
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(IRS Employer Identification Number)

~~Unit~~No. 18B-~~11, 18~~10-~~12 & 18-01~~08, ~~Tower A,~~ Vertical Business Suite,

~~Avenue 3,~~ Bangsar South City, No. 8 Jalan Kerinchi, 59200 Kuala Lumpur, Malaysia.

(Address of principal executive offices, &including zip code)

Issuer’s telephone number: (~~+60~~603) ~~327704032~~ 2242-4032

(~~Registrants~~Registrant’s telephone number, including area code)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a - 12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.~~13e~~13d-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class Trading Symbol(s) Name on each exchange on which registered ~~N/A~~Common ~~N/A~~Stock ~~N/A~~DQWS The OTC Market – OTCID

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging Growth Company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

ITEM 25.0102 ~~Completion~~Departure of ~~Acquisition~~Directors or ~~Disposition~~Certain Officers; Election of ~~Assets~~Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

~~Acquisition~~On October 1, 2025, the director of DSwiss, ~~Biotech~~Inc. ~~Sdn~~(the ~~Bhd~~“Company’), Sui Ting Wong tendered his resignation as Director of the Company (the “resignation”). Upon the resignation, Mr. Leong Ming Chia has become the sole director of the Company.

On March 17, 2016, DSwiss (HK) Limited (“DSHK”) invested in DSwiss Biotech Sdn Bhd (“DSBT”), a Company incorporated in Malaysia, and owned 40% of equity interest.

On January 18, 2023, DSwiss (HK) Limited acquired 150,000 shares (remaining 60% of total number of shares) of DSwiss Biotech Sdn Bhd from a shareholder, Jervey Choon, pursuant to which DSHK acquired 100% of DSBT. As consideration thereof, DSHK agreed to make the proceeds payment of USD 0.23 to the shareholder.

DSwiss Biotech Sdn Bhd primarily operates in Malaysia by supplying biotech products to their clients as set forth below:

Name Business Description DSwiss Biotech Sdn Bhd (Malaysia) Supply biotech products with in-house research and development. The company mainly focus on Malaysia clients.

An organizational chart of DSwiss, Inc. is set forth below:

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

99.1	Written Consent of the Board of Directors of the Company, dated October 1, 2025
104	Cover Page Interactive Data File (embedded within the Inline XBRL document)

Exhibit No.		Description
2.1		Sale and Purchase Agreement, dated as of January 18, 2023, between DSwiss (HK) Limited and Jervey Choon
104		Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized, at the location of Kuala Lumpur, Malaysia, on October 6, 2025.

	DSWISS, INC.
	(Name of Registrant)
Date: January 20, 2023
Date: October 6, 2025
	By:	/s/ ~~LEONG~~Leong ~~MING~~Ming ~~CHIA~~Chia
	Name:	Leong Ming Chia
	Title:	President, Chief Executive Officer, Chief Financial Officer, Treasurer, Secretary and Director (Principal Executive Officer, Principal Financial Officer)
		Chief Financial Officer, Treasurer, Secretary and Director
		(Principal Executive Officer, Principal Financial Officer)

Filing Compare · DSwiss Inc